Diabetic Retinopathy/Diabetic Macular Edema | TreatmentTrends | US | 2015

TreatmentTrends: Diabetic Retinopathy/Diabetic Macular Edema 2015 (US) is the fourth annual syndicated report series that offers a snapshot of DR and DME market dynamics and the competitive landscape through comprehensive primary research with retinal specialists and general ophthalmologists. The report provides valuable insight into the current and anticipated treatment of patients with DR (including nonproliferative DR [NPDR] and proliferative DR [PDR]) and DME (including focal and diffuse), with a particular focus on the use of intravitreal pharmacotherapies, specifically anti-VEGF agents and long-acting corticosteroid implants. We also assess surveyed physicians’ perceptions of these products for DME—e.g., their advantages and disadvantages, ideal patient types, barriers to growth—and current detailing and messaging efforts for approved DME brands. Respondents are queried about their awareness of and interest in products in development or recently approved for DR or DME.

Login to access report

launch Related Market Assessment Reports